Keyword Analysis & Research: oncotype
Keyword Research: People who searched oncotype also searched
Search Results related to oncotype on Search Engine
-
Oncotype DX | Susan G. Komen®
https://www.komen.org/breast-cancer/diagnosis/factors-that-affect-prognosis/oncotype-dx/
WebApr 11, 2024 · Oncotype DX is the most common tumor profiling test used in the U.S. and the only one used in breast cancer staging. Other tumor profiling tests, such as MammaPrint ®, are available. Oncotype DX testing. Oncotype DX tests a sample of the tumor (removed during a biopsy or surgery) for a group of 21 genes.
DA: 78 PA: 92 MOZ Rank: 40
-
Common Questions About the Oncotype DX® Test
https://www.mskcc.org/cancer-care/patient-education/oncotype-dx
WebJun 22, 2023 · What is the Oncotype DX test? The Oncotype DX is a test that looks at genes in breast cancer tissue. It may predict: Breast cancer prognosis (prog-NO-sis). Prognosis is the chance of the cancer coming back. If cancer comes back, it’s called recurrence (ree-KER-ents).
DA: 25 PA: 42 MOZ Rank: 71
-
Home | Precision Oncology
https://precisiononcology.exactsciences.com/
WebThe Oncotype DX ® tests deliver clinically relevant genomic intelligence specific to the individual biology of a patient’s tumor—equipping physicians with the Exact insights they need. Breast Cancer Tests; Prostate Cancer Tests; Colon Cancer Tests
DA: 50 PA: 77 MOZ Rank: 76
-
Oncotype DX Breast Recurrence Score® Test│ Precision Oncology
https://precisiononcology.exactsciences.com/healthcare-providers/treatment-determination/breast-cancer/oncotype-dx-breast-recurrence-score
WebThe Oncotype DX Breast Recurrence Score ® test provides personalized genomic insights for early-stage HR+, HER2- breast cancer patients. OVERVIEW. CLINICAL EVIDENCE. TEST COMPARISON. INTERPRETING THE RESULTS. RESOURCES. Order a Test. The only test proven to predict likelihood of chemotherapy benefit 1,2.
DA: 9 PA: 69 MOZ Rank: 55
-
Breast Cancer Gene Expression Tests | Tailor Your Treatment
https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-gene-expression.html
WebOncotype DX. The Oncotype DX test is used for stage I, II or IIIa hormone receptor-positive tumors that have not spread to more than 3 lymph nodes and are HER2 negative. It can also be used for DCIS (ductal carcinoma in situ or stage 0 breast cancer).
DA: 34 PA: 84 MOZ Rank: 51
-
Oncotype DX Tests for Early-Stage Breast Cancer and DCIS
https://www.breastcancer.org/screening-testing/oncotype-dx
WebThe Oncotype DX Breast Recurrence Score Test is used in two ways: to help doctors figure out a person’s risk of early-stage, estrogen receptor-positive breast cancer coming back in a part of the body away from the breast (distant recurrence) to help figure out if a person will benefit from chemotherapy.
DA: 85 PA: 92 MOZ Rank: 32
-
About the Oncotype DX Breast Recurrence Score® Test | Oncotype …
https://www.oncotypeiq.com/en-GB/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test
WebThe Oncotype DX Breast Recurrence Score ® test has been developed for patients with early-stage HR+, HER2- breast cancer to: Identify those patients who will derive benefit from chemotherapy. Determine the magnitude of chemotherapy benefit. Make chemotherapy a personalised treatment.
DA: 19 PA: 12 MOZ Rank: 71
-
Oncotype DX® | Exact Sciences
https://www.exactsciences.com/Our-Tests/Oncotype
WebOncotype genomic tests provide physicians and patients with personalized insights, allowing them to make treatment decisions with a greater degree of confidence.
DA: 27 PA: 52 MOZ Rank: 3
-
Oncotype DX | Breast Cancer Now
https://breastcancernow.org/about-breast-cancer/diagnosis/oncotype-dx/
Web1. What is the Oncotype DX test? Oncotype DX is a test that predicts how likely breast cancer is to spread to somewhere else in the body (secondary breast cancer) within 10 years of diagnosis, in people who will be taking hormone therapy for at least 5 years. 2. Who is Oncotype DX for?
DA: 23 PA: 2 MOZ Rank: 67
-
Personalising Treatment Decisions| Oncotype DX® Tests | Oncotype …
https://www.oncotypeiq.com/en/
WebOncotype DX ® tests. New Data. The only multigene assay commercially available proven to predict a patient’s individual benefit from chemotherapy. Learn More. The first multigene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease.
DA: 91 PA: 59 MOZ Rank: 89
